ChiCTR-IPR-17013756
尚未开始
/
/
/
2017-12-07
/
/
coronary heart disease (CHD)
Effects of a Group- plus Home-based Tai Chi Program on Improving Physical Function and Psychosocial Well-being in Patients with Coronary Heart Disease
Effects of a Group- plus Home-based Tai Chi Program on Improving Physical Function and Psychosocial Well-being in Patients with Coronary Heart Disease: A Randomized Controlled Trial
The study aims to conduct a group- plus home-based Tai Chi program for patients with CHD, which will beneficial in improving physical and psychosocial well-being
随机平行对照
探索性研究/预试验
Principle investigator will use the website "randomization.com" to generate the random number sequence, with the random block size is ten.
/
This study does not have funding support. Principle investigator (PI) is a PhD student, and this study is the PhD project. the PI will not seek funding from any parties
/
10
/
2017-12-14
2018-04-14
/
(1) have been diagnosed with CHD; (2) age > 18 years old； (3) be able to communicate in Chinese;；
登录查看(1) will have cardiac surgery planned during the following 6 months; (2) presence of unstable angina, severe congestive heart failure or severe pulmonary disease; (3) suffered from severe cognitive or sensory impairment (Abbreviated Mental Test score < 7) (4) have difficulty or inability to walk, or other incapacitating disabilities that may limit the practice of Tai Chi; (5) have previous training and practiced Tai Chi, or participated in other formal physical activity, within six months prior to the commencement of study.；
登录查看香港中文大學那打素護理學院
/
精准药物2024-11-23
亚泰制药2024-11-23
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
